In Change That Pushed Pazdur Out, FDA May Lower Clinical Trial Requirements
Commissioner Marty Makary said that the FDA will soon start requiring only one pivotal trial, instead of two, for companies seeking approval for new drugs.
In Change That Pushed Pazdur Out, FDA May Lower Clinical Trial Requirements Read More »
